Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Non-Hormonal Options for Menopausal Symptoms

Holter Monitoring in GP – Cases and Practical Tips

Management of Constipation in Children

Inhaler Devices – Common User Errors

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne